News
Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...
GlaxoSmithKline Pharmaceuticals on Friday said its consolidated net profit increased 12 per cent year-on-year to Rs 279 crore ...
GlaxoSmithKline Pharmaceuticals reports a 12% increase in net profit to Rs 279 crore for the June quarter despite a slight ...
GLAXOSMITHKLINE PHARMACEUTICALS LTD - Clarification sought from GlaxoSmithKline Pharmaceuticals Ltd - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and ...
1d
TipRanks on MSNGlaxoSmithKline Reports Strong Q2 2025 PerformanceGlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.
3d
BUCKSCO.Today on MSNGSK Partners with Chinese Pharma Co. in $500M DealPharma giant Glaxosmithkline, which has major operations in Upper Providence and West Point, is partnering with China-based ...
The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.
Graphite India Ltd, Glaxosmithkline Pharmaceuticals Ltd, IIFL Finance Ltd and K P R Mill Ltd are among the other losers in the BSE's 'A' group today, 01 August 2025.
British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for children.
GlaxoSmithKline said it would buy cancer-focused drug company Tesaro for about $4.16 billion, positioning the health-care giant in a promising, but fiercely competitive, area of medicine.
GlaxoSmithKline downgraded full-year earnings expectations, as its second-quarter profit was hit by currency moves, weak sales of its respiratory drugs and the continuing bribery investigation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results